Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Details
Prostorska sociologija v praksi
ID
Hočevar, Marjan
(
Author
)
URL - Presentation file, Visit
http://dk.fdv.uni-lj.si/db/pdfs/tip20102-3_Hocevar.pdf
Image galllery
Language:
Slovenian
Work type:
Not categorized
Typology:
1.04 - Professional Article
Organization:
FDV - Faculty of Social Sciences
Year:
2010
Number of pages:
Str. 280-282
Numbering:
Letn. 47, št. 2/3
PID:
20.500.12556/RUL-23098
UDC:
316.334
ISSN on article:
0040-3598
COBISS.SI-ID:
29465949
Publication date in RUL:
11.07.2014
Views:
1534
Downloads:
161
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
HOČEVAR, Marjan, 2010, Prostorska sociologija v praksi.
Teorija in praksa : revija za družbena vprašanja
[online]. 2010. Vol. 47, no. 2/3, p. 280–282. [Accessed 17 April 2025]. Retrieved from: http://dk.fdv.uni-lj.si/db/pdfs/tip20102-3_Hocevar.pdf
Copy citation
Share:
Record is a part of a journal
Title:
Teorija in praksa : revija za družbena vprašanja
Shortened title:
Teor. praksa
Publisher:
Fakulteta za družbene vede
ISSN:
0040-3598
COBISS.SI-ID:
763652
Similar documents
Similar works from RUL:
Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
Similar works from other Slovenian collections:
Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
Neurological adverse events of immune checkpoint inhibitors
Back